期刊文献+

比较左氧氟沙星与阿莫西林在三联疗法中根除幽门螺杆菌的作用 被引量:11

To compare the efficacy of levofloxacin with amoxicillin for Helicober pylori eradication in triple therapy
下载PDF
导出
摘要 目的比较左氧氟沙星与阿莫西林在三联疗法中根除幽门螺杆菌(Hp)的作用。方法选择213例符合条件的Hp阳性的慢性胃炎或消化性溃疡患者。随机分为两组。治疗组采取标准剂量的奥美拉唑(20mg,2次/日)加左氧氟沙星(200mg,2次/日),加呋喃唑酮(100mg,2次/日),治疗7天。对照组采取标准剂量的奥美拉唑(20mg,2次/日)加阿莫西林(1000mg,2次/日)加呋喃唑酮(100mg,2次/日),治疗7天。溃疡患者继用奥美拉唑20mg,1次/日,共3周。疗程结束4周后复查Hp,临床症状变化,溃疡愈合情况及不良反应等。观察Hp根除率,症状缓解率、溃疡愈合率及不良反应等。结果治疗组和对照组的症状缓解率、Hp根除率、溃疡治愈率、不良反应发生率分别为94.0%、88.0%、100.0%、16.0%和94.2%、83.7%、100.0%、8.1%。两组差异无显著性(P>0.05)。治疗组与对照组每例根除Hp费用分别为47.975元、38.875元。结论左氧氟沙星与阿莫西林在三联疗法中根除Hp疗效相仿且安全、经济,左氧氟沙星是根除Hp的理想新药,治疗组与对照组的方案均是根除Hp的理想方案。 Objective To compare the efficacy of levoffoxacin with amoxicillin for Helicobacter pylori(Hp) eradication in triple therapy. Methods A total of 213 Hp - positive patients suffering from chronic gastritis and peptic ulcer were randomized to treatment group and control group. The treatment group were administered standard omeprazole (20 mg, twice a day), levofloxacin (200 mg, twice a day)and furazolidone (100 mg, twice a day )for 7 days, while the control group received standard omeprazole (20 mg, twice a day), amoxicillin (1000 mg, twice a day)and furazolidone( 100 mg, twice a day)for 7 days. The patients with peptic ulcer were treated with omeprazole (20 mg, every day)for another three weeks. Four weeks later, the Hp eradication, symptoms, peptic ulcer healing and side - effects were observed. Results The symptom ameliorate rate, Hp eradication rate, peptic ulcer healing rate and side - effect rate between the treatment group and the control group were 94.0% and 94.2%, 88.0% and 83.7%, 100.0% and 100.0%, 16.0% and 8.1%, respectively. The difference was not significant ( P 〉 0.05 ). The cost of anti - Hp therapy of patient was 47. 975 yuan (RMB) and 38. 875 yuan (RMB) in the treatment group and control group respectively. Conclusion The effects of levofloxacin and amoxicillin in triple therapy are the same safe and economic. The levofloxacine is new and ideal drug eradicating Hp. Both regiments of the treatment group and control group are ideal Hp eradication ones.
出处 《安徽医学》 2007年第4期308-311,共4页 Anhui Medical Journal
基金 安徽省铜陵市卫生局2005年度科研项目(卫科研[2005]01)
关键词 左氧氟沙星 阿莫西林 幽门螺杆菌 药物疗法 Levofloxacin Amoxicillin Helicobacter pylori Drug therapy
  • 相关文献

参考文献18

二级参考文献37

  • 1萧树东.幽门螺杆菌的基础与临床研究[J].现代消化及介入诊疗,2003,8(3):136-137. 被引量:16
  • 2张万岱,胡伏莲,袁耀宗,徐智民,吴云林,程天明,牟方宏,魏红,孙菁,陈学清.瑞贝克三联一周疗法根除幽门螺杆菌的临床研究[J].现代消化及介入诊疗,2003,8(3):158-159. 被引量:9
  • 3黄跃,许鲁宁.环丙沙星一周疗法根除幽门螺杆菌[J].中国新药杂志,1994,3(2):34-36. 被引量:10
  • 4中华医学会.第二届全国幽门螺杆菌专题学术研究会关于幽门螺杆蓖若干问题的意见[J].胃肠病学和肝病杂志,1997,6(2):190-190.
  • 5赵庆卫.幽门螺杆菌研究现状[J].中国医学文摘:内科学分册,1999,20(6):702-704.
  • 6Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter Pylori Study Group(EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002,16:167-180.
  • 7Cammarota G, Cianci R, Cannizzaro O, et al. High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication[J]. J Clin Gastroenterol ,2004 ,38 ( 2 ) :110 -114.
  • 8Fakheri H, Merat S, Hosseini V ,et al. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication[ J ]. Aliment Pharmacol Ther,2004,19 ( 1 ) :89 - 93.
  • 9胡品津.Hp的耐药问题[J].中华消化杂志,2003,23(9):559-560.
  • 10Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Theatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1996,1:6-19.

共引文献693

同被引文献148

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部